Dexamethasone in severe respiratory COVID 19 saves lives---"Hot of the Press"
Dr. Baliga's 'Podkasts for Curious Docs'
Release Date: 06/16/2020
Fat, Fire, and Fibrosis 🔥🧬🛑 Unmasking the Metabolic Engine Driving MASLD
Dr. Baliga's 'Podkasts for Curious Docs'
🔬 New Insights on MASLD from JAMA 🍃 I recently reviewed an excellent JAMA article on Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD)—now recognized as the most common chronic liver disease worldwide. The review highlights how metabolic dysfunction, inflammation, and fibrosis converge to drive long-term risks, including cardiovascular disease, hepatocellular carcinoma, and extrahepatic cancers. Key advances include better noninvasive fibrosis assessment (FIB-4, elastography), strong evidence for lifestyle-driven weight loss, and new therapeutic momentum...
info_outline
The Brain's Hidden Rivers, Healing Flows, Hope Ahead
Dr. Baliga's 'Podkasts for Curious Docs'
In this week’s exploration, I dive into the brain’s hidden “plumbing”—the glymphatic and meningeal lymphatic systems—drawing from a remarkable report in Science magazine (Dec 2025). The piece outlines emerging Alzheimer’s strategies ranging from VEGF-C and Aquaporin-4 gene therapy to vasomotion drugs, CO₂ breathing, massage-based lymphatic stimulation, and even experimental lymphovenous surgery. A quiet revolution is underway—hope flowing through the brain’s deepest channels. 💧🌊 #Neuroscience #Alzheimers #ScienceMagazine #BrainHealth
info_outline
Obesity, Innovation, Action: The WHO Roadmap for GLP-1 Therapies 🌐🚀📘
Dr. Baliga's 'Podkasts for Curious Docs'
🌍 New WHO Guidance on GLP-1 Therapies: A Turning Point in Obesity Care 💉📘 The latest JAMA report highlights a pivotal moment in global health: the WHO’s evidence-informed guideline on GLP-1 therapies for adults living with obesity. With over 1 billion people affected worldwide, this chronic, relapsing disease demands integrated, equitable, lifelong care. The guidance underscores two essentials: 💊 Long-term GLP-1 therapy for those living with obesity 🤝 Intensive behavioral support to amplify and sustain benefits But the message is clear—medication alone...
info_outline
🔥 Activated Immunity, Aggravated Coronary Plaques, Accelerated ACS
Dr. Baliga's 'Podkasts for Curious Docs'
Delving into the latest JAHA review on immune checkpoint inhibitors and the heart has been illuminating 🔍❤️. As immunotherapy transforms cancer care, we’re learning that unleashed T-cells can also stir the silent storms within vulnerable plaques ⚡🩺. This piece beautifully unpacks how ICIs may accelerate atherosclerosis, heighten ACS risk, and challenge our diagnostic instincts—especially when myocarditis and ischemia mimic one another 🎯🧬. As we push the frontier of cancer survival, cardio-oncology must rise in parallel: better surveillance, smarter risk...
info_outline
Dr RR Baliga's Philosophical Discourses: Immanuel Kant (Germany, 1724–1804 CE) – Critique of Pure Reason
Dr. Baliga's 'Podkasts for Curious Docs'
Immanuel Kant: The Architect of Modern Reason 🧠✨ Fascinating to revisit Kant’s legacy — the thinker who reshaped how we understand knowledge, morality, and human freedom. His ideas on autonomy, duty, and the categorical imperative continue to guide ethical reasoning in science, leadership, and society. From Critique of Pure Reason to Perpetual Peace, Kant invites us to think boldly: What can I know? What should I do? What may I hope? 🌍📚 His work still challenges us to act with integrity, respect human dignity, and build a more rational and just world. ...
info_outline
📊 Detect, Diagnose, Defend: Protecting the Heart During ICI Therapy per IC-OS 🫀🧭🛡️
Dr. Baliga's 'Podkasts for Curious Docs'
🚀 Immune checkpoint inhibitors have transformed cancer care—but they come with a cardiovascular shadow. A new International Cardio-Oncology Society (IC-OS) position statement offers the clearest guidance yet on myocarditis, pericarditis, arrhythmias, ACS, and noninflammatory HF linked to ICI therapy. 🫀💡 Key insights include: • Early recognition with troponin, ECG, and CMR 🧪📊 • Smoldering vs. nonsevere vs. fulminant myocarditis distinctions 🔍 • Steroid-first management and the evolving role of abatacept + JAK inhibitors 💊 • Nuanced approaches to ICI...
info_outline
From GFR to Global Health: CKD’s Rising Tide 🌊📉🌐
Dr. Baliga's 'Podkasts for Curious Docs'
Chronic kidney disease now affects nearly 850 million people worldwide, yet early detection and simple, evidence-based interventions can dramatically change the trajectory of both kidney and cardiovascular health. 🌍🩺 The latest Lancet Seminar highlights powerful tools—eGFR + albuminuria staging, SGLT2 inhibitors, RAS blockade, statins, and GLP-1 therapies—that allow every clinician to make a measurable impact. 💊📉 A reminder that timely action is kidney protection. 💧✨
info_outline
📅🔍🧠: A Natural Experiment Reveals Dementia-Slowing Effects of Vaccination
Dr. Baliga's 'Podkasts for Curious Docs'
🚀 New insights from Cell shine a light on an unexpected ally in the fight against cognitive decline. A natural experiment from Wales shows that the shingles (herpes zoster) vaccine doesn’t just prevent viral reactivation—it may also reduce new mild cognitive impairment and lower dementia-related mortality over long-term follow-up. 🔍 Using a strict birthday-based eligibility cutoff, the study provides causal evidence—rare in population dementia research—that vaccination may slow disease across its entire course. 🧠✨ As we rethink neuroinflammation, immunosenescence, and...
info_outline
Covid, RSV, Influenza: The 2025–26 NEJM Update 🧬🔥📊
Dr. Baliga's 'Podkasts for Curious Docs'
📘 New NEJM Evidence for the 2025–26 Vaccine Season is out—and it delivers clarity at a time we need it most. The systematic review of 511 studies shows strong, consistent protection against hospitalization from Covid-19, RSV, and Influenza, with reassuring safety profiles across age groups. 💉🛡️ Key insights: improved VE for updated Covid-19 strains, high efficacy of maternal RSV vaccination and nirsevimab for infants, and solid influenza performance. 📊👶 A valuable guide for clinicians, health systems, and policymakers as we prepare for the upcoming...
info_outline
Winning Against HFrEF 🥇💓🛠 Diagnose Early. Treat with GDMT. Follow Through
Dr. Baliga's 'Podkasts for Curious Docs'
New Lancet Seminar on heart failure with reduced ejection fraction. 💓📘, this videocast walks listeners through the essentials of diagnosis, natriuretic peptides, imaging pathways, and the four foundational therapies shaping modern heart failure care. It’s a clear, evidence-driven journey—designed to inform, clarify, and elevate bedside practice. Tune in to explore the science, the strategy, and the future of treating HFrEF. 🫀🔬✨ 🫀🔬✨
info_outlineDr RR Baliga's 'Got Knowledge Doc' PodKasts for Physicians
Not Medical Advice or Opinion